OBJECTIVES: Technical limitations and evolution of therapeutic applications for cell culture-derived products have accelerated elimination of animal-derived constituents from such products to minimize inadvertent introduction of microbial contaminants, such as fungi, bacteria or viruses. The study described here was conducted to investigate the proliferative effect of vegetable peptone on adult stem cells in the absence of serum, and its possible mechanisms of action. MATERIALS AND METHODS: Cell viability and proliferation were determined using the MTT assay and Click-iT EdU flow cytometry, respectively. In addition, changes in expression of cytokine genes were analysed using MILLIPLEX human cytokine enzyme-linked immunosorbent assay kit. RESULTS: Viability of cord blood-derived mesenchymal stem cells (CB-MSC) and adipose tissue-derived stem cells (ADSC) increased significantly when treated with the peptone. In addition, median value of the group treated with peptone shifted to the right when compared to the untreated control group. Furthermore, quantitative analysis of the cytokines revealed that production of vascular endothelial growth factor (VEGF), transforming growth factor-beta1 (TGF-beta1), and interleukin-6 (IL-6) increased significantly in response to treatment with our vegetable peptone in both CB-MSCs and ADSCs. CONCLUSIONS: Our findings revealed that the vegetable peptone promotes proliferation of CB-MSCs and ADSCs. In addition, results of this study suggest that induction of stem cell proliferation by vegetable peptone is likely to be related to its induction of VEGF, TGF-beta1, and IL-6 expression.
OBJECTIVES: Technical limitations and evolution of therapeutic applications for cell culture-derived products have accelerated elimination of animal-derived constituents from such products to minimize inadvertent introduction of microbial contaminants, such as fungi, bacteria or viruses. The study described here was conducted to investigate the proliferative effect of vegetable peptone on adult stem cells in the absence of serum, and its possible mechanisms of action. MATERIALS AND METHODS: Cell viability and proliferation were determined using the MTT assay and Click-iT EdU flow cytometry, respectively. In addition, changes in expression of cytokine genes were analysed using MILLIPLEX human cytokine enzyme-linked immunosorbent assay kit. RESULTS: Viability of cord blood-derived mesenchymal stem cells (CB-MSC) and adipose tissue-derived stem cells (ADSC) increased significantly when treated with the peptone. In addition, median value of the group treated with peptone shifted to the right when compared to the untreated control group. Furthermore, quantitative analysis of the cytokines revealed that production of vascular endothelial growth factor (VEGF), transforming growth factor-beta1 (TGF-beta1), and interleukin-6 (IL-6) increased significantly in response to treatment with our vegetable peptone in both CB-MSCs and ADSCs. CONCLUSIONS: Our findings revealed that the vegetable peptone promotes proliferation of CB-MSCs and ADSCs. In addition, results of this study suggest that induction of stem cell proliferation by vegetable peptone is likely to be related to its induction of VEGF, TGF-beta1, and IL-6 expression.
Authors: Anne Eichmann; Li Yuan; Delphine Moyon; Ferdinand Lenoble; Luc Pardanaud; Christiane Breant Journal: Int J Dev Biol Date: 2005 Impact factor: 2.203
Authors: T A Fong; L K Shawver; L Sun; C Tang; H App; T J Powell; Y H Kim; R Schreck; X Wang; W Risau; A Ullrich; K P Hirth; G McMahon Journal: Cancer Res Date: 1999-01-01 Impact factor: 12.701
Authors: Girolamo Pelaia; Luca Gallelli; Bruno D'Agostino; Alessandro Vatrella; Giovanni Cuda; Donatella Fratto; Teresa Renda; Umberto Galderisi; Elena Piegari; Nunzio Crimi; Francesco Rossi; Mario Caputi; Francesco S Costanzo; Carlo Vancheri; Rosario Maselli; Serafino A Marsico Journal: J Cell Physiol Date: 2007-02 Impact factor: 6.384
Authors: L M Strawn; G McMahon; H App; R Schreck; W R Kuchler; M P Longhi; T H Hui; C Tang; A Levitzki; A Gazit; I Chen; G Keri; L Orfi; W Risau; I Flamme; A Ullrich; K P Hirth; L K Shawver Journal: Cancer Res Date: 1996-08-01 Impact factor: 12.701
Authors: Takafumi Kimura; Andreas M Boehmler; Gabriele Seitz; Selim Kuçi; Tina Wiesner; Volker Brinkmann; Lothar Kanz; Robert Möhle Journal: Blood Date: 2004-02-26 Impact factor: 22.113